Recruiting OBSERVATIONAL NCT06512753
The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical Care: a Patient Preference Trial (HEMLET)
Sponsor: Erasmus Medical Center
Conditions
Cicatricial Alopecia Lichen Planopilaris
Interventions
Hydroxychloroquine Methotrexate
Updated 2 times since 2024 Last updated: Jul 16, 2024 Started: Jul 1, 2024 Primary completion: Jul 1, 2026 Completion: Jul 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06512753, this observational or N/A phase trial focuses on Cicatricial Alopecia and Lichen Planopilaris and remains actively recruiting participants. Sponsored by Erasmus Medical Center, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
First recorded
Jul 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Erasmus Medical Center
Data source: Erasmus Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .